Go to content

Protective effects of leukotriene receptor antagonists (LTRAs) in dementia and Alzheimer’s disease (AD)

Project ID: 2020-795/ TRIM 2022 0970 269 000

Principle Investigator: Walter Swardfager

Description: The purpose of this research is to determine if LTRAs, namely Montelukast and Zafirlukast, have a protective effect on the development of dementia and specifically, AD dementia in a cohort of Ontario residents aged 65+.

PIA approved: March 31, 2021